TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
SDS Life Science AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
80,515
|
75,490
|
65,413 |
Financial expenses |
675
|
1,321
|
12 |
Earnings before taxes |
-3,426
|
-2,343
|
2,429 |
EBITDA |
-1,962
|
-1,028
|
2,462 |
Total assets |
28,495
|
28,545
|
31,459 |
Current assets |
24,172
|
25,001
|
31,255 |
Current liabilities |
13,026
|
12,604
|
13,480 |
Equity capital |
2,705
|
995
|
1,216 |
- share capital |
203
|
189
|
195 |
Employees (average) |
50
|
45
|
34 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
9.5%
|
3.5%
|
3.9% |
Turnover per employee |
1,610
|
1,678
|
1,924 |
Profit as a percentage of turnover |
-4.3%
|
-3.1%
|
3.7% |
Return on assets (ROA) |
-9.7%
|
-3.6%
|
7.8% |
Current ratio |
185.6%
|
198.4%
|
231.9% |
Return on equity (ROE) |
-126.7%
|
-235.5%
|
199.8% |
Change turnover |
-331
|
12,042
|
7,228 |
Change turnover % |
0%
|
19%
|
12% |
Chg. No. of employees |
5
|
11
|
7 |
Chg. No. of employees % |
11%
|
32%
|
26% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.